

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.60732693 |
| 2 | viral transcription (GO:0019083) | 5.20007209 |
| 3 | translational termination (GO:0006415) | 5.03202699 |
| 4 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.80578680 |
| 5 | protein targeting to ER (GO:0045047) | 4.68201888 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 4.64155245 |
| 7 | translational elongation (GO:0006414) | 4.50067942 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 4.45249889 |
| 9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.44685092 |
| 10 | protein localization to endoplasmic reticulum (GO:0070972) | 4.34816743 |
| 11 | translational initiation (GO:0006413) | 4.15008486 |
| 12 | GDP-mannose metabolic process (GO:0019673) | 4.14625463 |
| 13 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.11571322 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 4.10589335 |
| 15 | viral life cycle (GO:0019058) | 4.01876759 |
| 16 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.98129084 |
| 17 | formation of translation preinitiation complex (GO:0001731) | 3.98065166 |
| 18 | cellular protein complex disassembly (GO:0043624) | 3.92441944 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.80825510 |
| 20 | DNA strand elongation (GO:0022616) | 3.77218177 |
| 21 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.68326806 |
| 22 | ribosomal large subunit biogenesis (GO:0042273) | 3.67327030 |
| 23 | DNA unwinding involved in DNA replication (GO:0006268) | 3.61684125 |
| 24 | protein complex disassembly (GO:0043241) | 3.52202107 |
| 25 | protein localization to kinetochore (GO:0034501) | 3.48964558 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 3.38477912 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 3.38477912 |
| 28 | telomere maintenance via recombination (GO:0000722) | 3.37390621 |
| 29 | proteasome assembly (GO:0043248) | 3.34330761 |
| 30 | DNA replication initiation (GO:0006270) | 3.33103462 |
| 31 | macromolecular complex disassembly (GO:0032984) | 3.31165142 |
| 32 | translation (GO:0006412) | 3.18237123 |
| 33 | mitotic recombination (GO:0006312) | 3.13445413 |
| 34 | protein maturation by protein folding (GO:0022417) | 3.13357784 |
| 35 | protein targeting to membrane (GO:0006612) | 3.09971458 |
| 36 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.08214550 |
| 37 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.07293716 |
| 38 | ncRNA 3-end processing (GO:0043628) | 3.01568869 |
| 39 | mitotic nuclear envelope disassembly (GO:0007077) | 3.01408686 |
| 40 | regulation of chemokine biosynthetic process (GO:0045073) | 2.98228200 |
| 41 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.97273271 |
| 42 | DNA deamination (GO:0045006) | 2.97059552 |
| 43 | T cell apoptotic process (GO:0070231) | 2.95960868 |
| 44 | telomere maintenance via telomere lengthening (GO:0010833) | 2.95264713 |
| 45 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.94038920 |
| 46 | mRNA catabolic process (GO:0006402) | 2.93021580 |
| 47 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.91961480 |
| 48 | regulation of protein heterodimerization activity (GO:0043497) | 2.90732313 |
| 49 | positive regulation of prostaglandin secretion (GO:0032308) | 2.90526578 |
| 50 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.89970292 |
| 51 | regulation of vitamin metabolic process (GO:0030656) | 2.89880293 |
| 52 | RNA catabolic process (GO:0006401) | 2.89352381 |
| 53 | protein localization to chromosome, centromeric region (GO:0071459) | 2.89155875 |
| 54 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.88422339 |
| 55 | DNA replication checkpoint (GO:0000076) | 2.87680576 |
| 56 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.85784301 |
| 57 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.85695414 |
| 58 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.85108810 |
| 59 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.85108810 |
| 60 | IMP biosynthetic process (GO:0006188) | 2.84990662 |
| 61 | glycosphingolipid catabolic process (GO:0046479) | 2.82339659 |
| 62 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.80350705 |
| 63 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80333077 |
| 64 | negative regulation of ligase activity (GO:0051352) | 2.79172912 |
| 65 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.79172912 |
| 66 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.78651835 |
| 67 | nuclear envelope disassembly (GO:0051081) | 2.76164672 |
| 68 | membrane disassembly (GO:0030397) | 2.76164672 |
| 69 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.75739759 |
| 70 | regulation of mitochondrial translation (GO:0070129) | 2.74993752 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72184840 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.72184840 |
| 73 | regulation of chronic inflammatory response (GO:0002676) | 2.70039868 |
| 74 | nucleobase biosynthetic process (GO:0046112) | 2.69919965 |
| 75 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.68552126 |
| 76 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.67498950 |
| 77 | maternal placenta development (GO:0001893) | 2.65012155 |
| 78 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.64114548 |
| 79 | rRNA processing (GO:0006364) | 2.61301648 |
| 80 | glycolipid catabolic process (GO:0019377) | 2.60730566 |
| 81 | regulation of prostaglandin secretion (GO:0032306) | 2.60534511 |
| 82 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.59319588 |
| 83 | pseudouridine synthesis (GO:0001522) | 2.58985112 |
| 84 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.58303775 |
| 85 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.57268709 |
| 86 | negative regulation of RNA splicing (GO:0033119) | 2.57163713 |
| 87 | rRNA metabolic process (GO:0016072) | 2.55158221 |
| 88 | regulation of translational termination (GO:0006449) | 2.54880462 |
| 89 | protein retention in ER lumen (GO:0006621) | 2.52528890 |
| 90 | NIK/NF-kappaB signaling (GO:0038061) | 2.52372248 |
| 91 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.52240612 |
| 92 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.52117636 |
| 93 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.52117636 |
| 94 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.51841472 |
| 95 | oligosaccharide catabolic process (GO:0009313) | 2.51517844 |
| 96 | lymphocyte apoptotic process (GO:0070227) | 2.51183691 |
| 97 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.50882478 |
| 98 | response to interferon-beta (GO:0035456) | 2.50817566 |
| 99 | heterochromatin organization (GO:0070828) | 2.49783413 |
| 100 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.49745685 |
| 101 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.49745685 |
| 102 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.49745685 |
| 103 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.49106946 |
| 104 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.49106946 |
| 105 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.49061008 |
| 106 | pentose metabolic process (GO:0019321) | 2.47255520 |
| 107 | mitotic sister chromatid segregation (GO:0000070) | 2.47097811 |
| 108 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.46921489 |
| 109 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.46305837 |
| 110 | proline biosynthetic process (GO:0006561) | 2.45354942 |
| 111 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.44936622 |
| 112 | IMP metabolic process (GO:0046040) | 2.44529608 |
| 113 | regulation of podosome assembly (GO:0071801) | 2.44108136 |
| 114 | immunoglobulin mediated immune response (GO:0016064) | 2.42946904 |
| 115 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.42860963 |
| 116 | ribosome biogenesis (GO:0042254) | 2.42298169 |
| 117 | pinocytosis (GO:0006907) | 2.41295825 |
| 118 | mitotic metaphase plate congression (GO:0007080) | 2.40920041 |
| 119 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40901097 |
| 120 | ribosome assembly (GO:0042255) | 2.40678471 |
| 121 | mature B cell differentiation involved in immune response (GO:0002313) | 2.40589643 |
| 122 | ceramide catabolic process (GO:0046514) | 2.40243163 |
| 123 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.39461645 |
| 124 | negative regulation of interleukin-12 production (GO:0032695) | 2.38587308 |
| 125 | chromatin remodeling at centromere (GO:0031055) | 2.36398981 |
| 126 | regulation of superoxide anion generation (GO:0032928) | 2.35910954 |
| 127 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.35229117 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.34914961 |
| 129 | DNA duplex unwinding (GO:0032508) | 2.34800866 |
| 130 | pentose-phosphate shunt (GO:0006098) | 2.34610392 |
| 131 | nucleotide salvage (GO:0043173) | 2.34265506 |
| 132 | hepatocyte apoptotic process (GO:0097284) | 2.34172238 |
| 133 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.33803794 |
| 134 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.32958601 |
| 135 | DNA geometric change (GO:0032392) | 2.32843989 |
| 136 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.32770806 |
| 137 | CENP-A containing nucleosome assembly (GO:0034080) | 2.32365902 |
| 138 | sister chromatid segregation (GO:0000819) | 2.32330208 |
| 139 | nuclear pore organization (GO:0006999) | 2.32089976 |
| 140 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.32026269 |
| 141 | maturation of 5.8S rRNA (GO:0000460) | 2.31806934 |
| 142 | cellular response to interferon-beta (GO:0035458) | 2.31064570 |
| 143 | pyrimidine-containing compound salvage (GO:0008655) | 2.29898486 |
| 144 | pyrimidine nucleoside salvage (GO:0043097) | 2.29898486 |
| 145 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.29796978 |
| 146 | negative regulation of B cell apoptotic process (GO:0002903) | 2.29737247 |
| 147 | purine nucleobase biosynthetic process (GO:0009113) | 2.29361623 |
| 148 | telomere maintenance (GO:0000723) | 2.29351838 |
| 149 | purine nucleotide salvage (GO:0032261) | 2.27473258 |
| 150 | telomere organization (GO:0032200) | 2.27360167 |
| 151 | leukocyte apoptotic process (GO:0071887) | 2.26698657 |
| 152 | regulation of interferon-alpha production (GO:0032647) | 2.26626123 |
| 153 | translesion synthesis (GO:0019985) | 2.26533118 |
| 154 | kinetochore organization (GO:0051383) | 2.26046089 |
| 155 | mitotic chromosome condensation (GO:0007076) | 2.25974916 |
| 156 | DNA replication-independent nucleosome organization (GO:0034724) | 2.25276937 |
| 157 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.25276937 |
| 158 | positive regulation of ligase activity (GO:0051351) | 2.25227711 |
| 159 | protein autoprocessing (GO:0016540) | 2.24987397 |
| 160 | response to peptidoglycan (GO:0032494) | 2.24757106 |
| 161 | protein targeting to mitochondrion (GO:0006626) | 2.24478825 |
| 162 | rRNA modification (GO:0000154) | 2.23722477 |
| 163 | nuclear envelope reassembly (GO:0031468) | 2.23621326 |
| 164 | mitotic nuclear envelope reassembly (GO:0007084) | 2.23621326 |
| 165 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.23329086 |
| 166 | oxidative phosphorylation (GO:0006119) | 2.22855468 |
| 167 | spliceosomal snRNP assembly (GO:0000387) | 2.22658877 |
| 168 | regulation of mitochondrial membrane potential (GO:0051881) | 2.21842020 |
| 169 | nuclear pore complex assembly (GO:0051292) | 2.20705374 |
| 170 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.20691320 |
| 171 | base-excision repair (GO:0006284) | 2.20065221 |
| 172 | cellular response to arsenic-containing substance (GO:0071243) | 2.19555814 |
| 173 | membrane lipid catabolic process (GO:0046466) | 2.19286842 |
| 174 | tetrahydrofolate metabolic process (GO:0046653) | 2.19274821 |
| 175 | sphingolipid catabolic process (GO:0030149) | 2.19128069 |
| 176 | deoxyribonucleotide catabolic process (GO:0009264) | 2.18996946 |
| 177 | histone-serine phosphorylation (GO:0035404) | 2.18472229 |
| 178 | ATP synthesis coupled proton transport (GO:0015986) | 2.18133539 |
| 179 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.18133539 |
| 180 | chaperone-mediated protein transport (GO:0072321) | 2.17573644 |
| 181 | regulation of RIG-I signaling pathway (GO:0039535) | 2.17504598 |
| 182 | chromatin assembly or disassembly (GO:0006333) | 2.14978959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.05525884 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.70287128 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.50335690 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.26976999 |
| 5 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.60313977 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.59080499 |
| 7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.51949859 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43196188 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.25915490 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.24195411 |
| 11 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.20526626 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20169994 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.11549550 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.06082983 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.05030686 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04912550 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.01927485 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.01584581 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96307135 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95499288 |
| 21 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94631477 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.92553878 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.87552059 |
| 24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82937072 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82747854 |
| 26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82007042 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81368634 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.79390450 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.77800703 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.77051091 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.70128589 |
| 32 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.64338103 |
| 33 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.64008822 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63622468 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.59826413 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58987076 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.58737251 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58491500 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.57554643 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.55269101 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54074045 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52685908 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.51970904 |
| 44 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51736953 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.48442843 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47269913 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46516908 |
| 48 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46262962 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42384959 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41758780 |
| 51 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41017289 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40754500 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39245459 |
| 54 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.38119866 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37549482 |
| 56 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35931018 |
| 57 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35878843 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35728951 |
| 59 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34541360 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32779804 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31585586 |
| 62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31209508 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30926846 |
| 64 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.30628383 |
| 65 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28493304 |
| 66 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28181088 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27587361 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.25820492 |
| 69 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.25177754 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24676639 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24506030 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.22674712 |
| 73 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20423663 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20246223 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.18542015 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 1.18365580 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18230506 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17933373 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17613880 |
| 80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17365078 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16949318 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15435126 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15139121 |
| 84 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14777530 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14455588 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13810388 |
| 87 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13754529 |
| 88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13257950 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13161704 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12472320 |
| 91 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10009468 |
| 92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09766720 |
| 93 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09670539 |
| 94 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.09301532 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08142657 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06949344 |
| 97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05964678 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04760634 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03167331 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 1.02775010 |
| 101 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02684572 |
| 102 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02194069 |
| 103 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.01559649 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01429558 |
| 105 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01154274 |
| 106 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00831869 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99924412 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99486855 |
| 109 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99221221 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98584100 |
| 111 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.98415405 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97969995 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97811625 |
| 114 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97647597 |
| 115 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96130618 |
| 116 | MYB_26560356_Chip-Seq_TH1_Human | 0.96041914 |
| 117 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95800705 |
| 118 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95183496 |
| 119 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.94973140 |
| 120 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93180059 |
| 121 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.92838156 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92687660 |
| 123 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92364909 |
| 124 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.91408875 |
| 125 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90051452 |
| 126 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89725233 |
| 127 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89700635 |
| 128 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88605404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.67145077 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.20010498 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 2.91119188 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 2.84770874 |
| 5 | MP0009840_abnormal_foam_cell | 2.78638026 |
| 6 | MP0005451_abnormal_body_composition | 2.73178753 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.44383059 |
| 8 | MP0000490_abnormal_crypts_of | 2.43493698 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.39283381 |
| 10 | MP0003077_abnormal_cell_cycle | 2.38127741 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.33056038 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.31456892 |
| 13 | MP0006054_spinal_hemorrhage | 1.97941530 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 1.92219580 |
| 15 | MP0006082_CNS_inflammation | 1.91499540 |
| 16 | MP0002396_abnormal_hematopoietic_system | 1.90610900 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 1.82628681 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.81790137 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.80827028 |
| 20 | MP0005076_abnormal_cell_differentiation | 1.80281795 |
| 21 | MP0008007_abnormal_cellular_replicative | 1.78338135 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.77936046 |
| 23 | MP0010307_abnormal_tumor_latency | 1.75052270 |
| 24 | MP0001873_stomach_inflammation | 1.68925999 |
| 25 | MP0003436_decreased_susceptibility_to | 1.68571137 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.68275234 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.66917037 |
| 28 | MP0000858_altered_metastatic_potential | 1.63830534 |
| 29 | MP0000685_abnormal_immune_system | 1.61772336 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.59666309 |
| 31 | MP0009764_decreased_sensitivity_to | 1.58480539 |
| 32 | MP0000350_abnormal_cell_proliferation | 1.57281750 |
| 33 | MP0000343_altered_response_to | 1.54837638 |
| 34 | MP0008057_abnormal_DNA_replication | 1.54739078 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.54028080 |
| 36 | MP0005083_abnormal_biliary_tract | 1.51688448 |
| 37 | MP0001730_embryonic_growth_arrest | 1.48575005 |
| 38 | MP0003075_altered_response_to | 1.46890839 |
| 39 | MP0003866_abnormal_defecation | 1.44401799 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.44021131 |
| 41 | MP0008932_abnormal_embryonic_tissue | 1.43732004 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43528289 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.42542851 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.39933991 |
| 45 | MP0004264_abnormal_extraembryonic_tissu | 1.39233365 |
| 46 | MP0008058_abnormal_DNA_repair | 1.38764307 |
| 47 | MP0002398_abnormal_bone_marrow | 1.38366987 |
| 48 | MP0002006_tumorigenesis | 1.38057249 |
| 49 | MP0003303_peritoneal_inflammation | 1.36504859 |
| 50 | MP0005023_abnormal_wound_healing | 1.35116289 |
| 51 | MP0002019_abnormal_tumor_incidence | 1.34935249 |
| 52 | MP0001800_abnormal_humoral_immune | 1.34289509 |
| 53 | MP0008469_abnormal_protein_level | 1.33489215 |
| 54 | MP0009785_altered_susceptibility_to | 1.33456496 |
| 55 | MP0002254_reproductive_system_inflammat | 1.32187331 |
| 56 | MP0005165_increased_susceptibility_to | 1.31519656 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.30779119 |
| 58 | MP0003123_paternal_imprinting | 1.29333095 |
| 59 | MP0005671_abnormal_response_to | 1.29161722 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.26473071 |
| 61 | MP0001819_abnormal_immune_cell | 1.25255281 |
| 62 | MP0002405_respiratory_system_inflammati | 1.25247606 |
| 63 | MP0002722_abnormal_immune_system | 1.25186106 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.24710097 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.24501684 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.23867958 |
| 67 | MP0005025_abnormal_response_to | 1.22207696 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.18546470 |
| 69 | MP0000477_abnormal_intestine_morphology | 1.18330363 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.17537063 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.17537063 |
| 72 | MP0001881_abnormal_mammary_gland | 1.17026818 |
| 73 | MP0005365_abnormal_bile_salt | 1.16760158 |
| 74 | MP0004947_skin_inflammation | 1.15131632 |
| 75 | MP0002429_abnormal_blood_cell | 1.13256555 |
| 76 | MP0002723_abnormal_immune_serum | 1.13183614 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.12731471 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 1.10881613 |
| 79 | MP0000716_abnormal_immune_system | 1.10517941 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.10017275 |
| 81 | MP0001697_abnormal_embryo_size | 1.09908662 |
| 82 | MP0002080_prenatal_lethality | 1.08996929 |
| 83 | MP0000537_abnormal_urethra_morphology | 1.08420008 |
| 84 | MP0005387_immune_system_phenotype | 1.08347484 |
| 85 | MP0001790_abnormal_immune_system | 1.08347484 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.06404825 |
| 87 | MP0000313_abnormal_cell_death | 1.05147519 |
| 88 | MP0002086_abnormal_extraembryonic_tissu | 1.04262104 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 1.03295961 |
| 90 | MP0001542_abnormal_bone_strength | 1.02576437 |
| 91 | MP0005380_embryogenesis_phenotype | 1.02410974 |
| 92 | MP0001672_abnormal_embryogenesis/_devel | 1.02410974 |
| 93 | MP0003718_maternal_effect | 1.01367925 |
| 94 | MP0001727_abnormal_embryo_implantation | 1.01046352 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 1.00916212 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 1.00183997 |
| 97 | MP0003448_altered_tumor_morphology | 0.99970438 |
| 98 | MP0008260_abnormal_autophagy | 0.99260397 |
| 99 | MP0003984_embryonic_growth_retardation | 0.98688356 |
| 100 | MP0002088_abnormal_embryonic_growth/wei | 0.96781499 |
| 101 | MP0004510_myositis | 0.96427109 |
| 102 | MP0001764_abnormal_homeostasis | 0.96211768 |
| 103 | MP0001849_ear_inflammation | 0.94003266 |
| 104 | MP0009379_abnormal_foot_pigmentation | 0.92717112 |
| 105 | MP0002419_abnormal_innate_immunity | 0.92171619 |
| 106 | MP0005220_abnormal_exocrine_pancreas | 0.92103966 |
| 107 | MP0005310_abnormal_salivary_gland | 0.91663079 |
| 108 | MP0001663_abnormal_digestive_system | 0.90510228 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.90272026 |
| 110 | MP0005464_abnormal_platelet_physiology | 0.89726449 |
| 111 | MP0009763_increased_sensitivity_to | 0.88893967 |
| 112 | MP0000609_abnormal_liver_physiology | 0.88169794 |
| 113 | MP0000678_abnormal_parathyroid_gland | 0.87375695 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.87284450 |
| 115 | MP0003786_premature_aging | 0.86852211 |
| 116 | MP0002085_abnormal_embryonic_tissue | 0.86529512 |
| 117 | MP0006035_abnormal_mitochondrial_morpho | 0.86312426 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.85901779 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.85374253 |
| 120 | MP0005360_urolithiasis | 0.85367000 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83902203 |
| 122 | MP0003724_increased_susceptibility_to | 0.83363242 |
| 123 | MP0003186_abnormal_redox_activity | 0.83287497 |
| 124 | MP0001533_abnormal_skeleton_physiology | 0.82668563 |
| 125 | MP0005166_decreased_susceptibility_to | 0.81826816 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.81413541 |
| 127 | MP0009278_abnormal_bone_marrow | 0.80940230 |
| 128 | MP0002277_abnormal_respiratory_mucosa | 0.80820403 |
| 129 | MP0002132_abnormal_respiratory_system | 0.79979096 |
| 130 | MP0000358_abnormal_cell_content/ | 0.78952139 |
| 131 | MP0004043_abnormal_pH_regulation | 0.78183657 |
| 132 | MP0002084_abnormal_developmental_patter | 0.75719546 |
| 133 | MP0001243_abnormal_dermal_layer | 0.73502055 |
| 134 | MP0001853_heart_inflammation | 0.73401411 |
| 135 | MP0005501_abnormal_skin_physiology | 0.72851239 |
| 136 | MP0009053_abnormal_anal_canal | 0.72835510 |
| 137 | MP0005381_digestive/alimentary_phenotyp | 0.71433395 |
| 138 | MP0002060_abnormal_skin_morphology | 0.71231873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.15000986 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.15000986 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.15000986 |
| 4 | Reticulocytopenia (HP:0001896) | 4.48150477 |
| 5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.03956142 |
| 6 | Thrombocytosis (HP:0001894) | 3.73286313 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 3.70913179 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.32244994 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09628645 |
| 10 | Dysostosis multiplex (HP:0000943) | 2.91930242 |
| 11 | Pallor (HP:0000980) | 2.89703382 |
| 12 | Trismus (HP:0000211) | 2.81957812 |
| 13 | Degeneration of anterior horn cells (HP:0002398) | 2.76327577 |
| 14 | Abnormality of the anterior horn cell (HP:0006802) | 2.76327577 |
| 15 | Aplastic anemia (HP:0001915) | 2.73747655 |
| 16 | Hypertensive crisis (HP:0100735) | 2.72793679 |
| 17 | 11 pairs of ribs (HP:0000878) | 2.71784973 |
| 18 | Multiple enchondromatosis (HP:0005701) | 2.70200662 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.65998191 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 2.65551415 |
| 21 | Increased serum ferritin (HP:0003281) | 2.63823935 |
| 22 | Macrocytic anemia (HP:0001972) | 2.63560196 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.61239934 |
| 24 | Colon cancer (HP:0003003) | 2.60625387 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.60481090 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.60481090 |
| 27 | Ragged-red muscle fibers (HP:0003200) | 2.60041127 |
| 28 | Nausea (HP:0002018) | 2.58983490 |
| 29 | Increased CSF lactate (HP:0002490) | 2.54605724 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 2.52256898 |
| 31 | Hepatosplenomegaly (HP:0001433) | 2.50489425 |
| 32 | Acute necrotizing encephalopathy (HP:0006965) | 2.48222735 |
| 33 | Pustule (HP:0200039) | 2.47082796 |
| 34 | Selective tooth agenesis (HP:0001592) | 2.43931667 |
| 35 | Esophageal neoplasm (HP:0100751) | 2.42237869 |
| 36 | Neoplasm of head and neck (HP:0012288) | 2.42237869 |
| 37 | Microretrognathia (HP:0000308) | 2.38593967 |
| 38 | Mitochondrial inheritance (HP:0001427) | 2.38143937 |
| 39 | Acute encephalopathy (HP:0006846) | 2.37953724 |
| 40 | Microvesicular hepatic steatosis (HP:0001414) | 2.37763985 |
| 41 | Petechiae (HP:0000967) | 2.36759062 |
| 42 | Increased serum pyruvate (HP:0003542) | 2.33570558 |
| 43 | Axonal loss (HP:0003447) | 2.33262127 |
| 44 | Hepatocellular necrosis (HP:0001404) | 2.32577637 |
| 45 | Prolonged neonatal jaundice (HP:0006579) | 2.31365255 |
| 46 | Hepatic necrosis (HP:0002605) | 2.31037372 |
| 47 | Testicular atrophy (HP:0000029) | 2.30600243 |
| 48 | Loss of speech (HP:0002371) | 2.28441345 |
| 49 | Abnormal trabecular bone morphology (HP:0100671) | 2.25405709 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.25035537 |
| 51 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.24106385 |
| 52 | Increased serum lactate (HP:0002151) | 2.23227814 |
| 53 | IgM deficiency (HP:0002850) | 2.21837456 |
| 54 | Abnormality of glycolysis (HP:0004366) | 2.20598573 |
| 55 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.19919470 |
| 56 | Breast hypoplasia (HP:0003187) | 2.15398886 |
| 57 | Cervical subluxation (HP:0003308) | 2.15079909 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.14803501 |
| 59 | Cholecystitis (HP:0001082) | 2.14803501 |
| 60 | Missing ribs (HP:0000921) | 2.14179478 |
| 61 | Deviation of the thumb (HP:0009603) | 2.13318481 |
| 62 | Obstructive lung disease (HP:0006536) | 2.12593596 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12593596 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10542848 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10542848 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10542848 |
| 67 | Ileus (HP:0002595) | 2.10377405 |
| 68 | Abnormality of macrophages (HP:0004311) | 2.09492200 |
| 69 | Lactic acidosis (HP:0003128) | 2.08076370 |
| 70 | Autoimmune hemolytic anemia (HP:0001890) | 2.07492733 |
| 71 | Abnormality of T cells (HP:0002843) | 2.07227635 |
| 72 | Recurrent viral infections (HP:0004429) | 2.02385945 |
| 73 | Abnormality of the calcaneus (HP:0008364) | 1.99550892 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 1.99491915 |
| 75 | Neoplasm of the pancreas (HP:0002894) | 1.98264331 |
| 76 | Micronodular cirrhosis (HP:0001413) | 1.97173275 |
| 77 | Cerebral edema (HP:0002181) | 1.96870050 |
| 78 | Basal cell carcinoma (HP:0002671) | 1.94674078 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 1.94219781 |
| 80 | Proximal placement of thumb (HP:0009623) | 1.94181904 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93043865 |
| 82 | Opisthotonus (HP:0002179) | 1.92262946 |
| 83 | Type I transferrin isoform profile (HP:0003642) | 1.91932083 |
| 84 | Recurrent abscess formation (HP:0002722) | 1.90653455 |
| 85 | Cellulitis (HP:0100658) | 1.90318406 |
| 86 | Myocardial infarction (HP:0001658) | 1.89183436 |
| 87 | Abnormality of reticulocytes (HP:0004312) | 1.88961443 |
| 88 | Recurrent fungal infections (HP:0002841) | 1.88932369 |
| 89 | Mucopolysacchariduria (HP:0008155) | 1.88876145 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88876145 |
| 91 | Rough bone trabeculation (HP:0100670) | 1.87499496 |
| 92 | Respiratory failure (HP:0002878) | 1.85355727 |
| 93 | Oral leukoplakia (HP:0002745) | 1.84952359 |
| 94 | Carpal bone hypoplasia (HP:0001498) | 1.84396502 |
| 95 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.81762338 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81550276 |
| 97 | Generalized aminoaciduria (HP:0002909) | 1.80926737 |
| 98 | Increased muscle lipid content (HP:0009058) | 1.79244911 |
| 99 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.79001829 |
| 100 | Nuclear cataract (HP:0100018) | 1.77552113 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.77307210 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 1.77307210 |
| 103 | Birth length less than 3rd percentile (HP:0003561) | 1.77305286 |
| 104 | Hypokinesia (HP:0002375) | 1.77127981 |
| 105 | Ependymoma (HP:0002888) | 1.76819958 |
| 106 | Abnormal foot bone ossification (HP:0010675) | 1.76390039 |
| 107 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75736318 |
| 108 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.75169305 |
| 109 | Abnormality of the umbilical cord (HP:0010881) | 1.74766027 |
| 110 | Glossoptosis (HP:0000162) | 1.74234397 |
| 111 | Absent thumb (HP:0009777) | 1.74067702 |
| 112 | Entropion (HP:0000621) | 1.73800325 |
| 113 | Increased density of long bones (HP:0006392) | 1.73516218 |
| 114 | J-shaped sella turcica (HP:0002680) | 1.73505420 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 1.72852876 |
| 116 | Patellar aplasia (HP:0006443) | 1.71682662 |
| 117 | Vertebral hypoplasia (HP:0008417) | 1.71482818 |
| 118 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.71482818 |
| 119 | Pancytopenia (HP:0001876) | 1.71461006 |
| 120 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.70711615 |
| 121 | Amaurosis fugax (HP:0100576) | 1.70520389 |
| 122 | Purpura (HP:0000979) | 1.70463813 |
| 123 | Recurrent bacterial skin infections (HP:0005406) | 1.70110120 |
| 124 | Abnormal protein glycosylation (HP:0012346) | 1.69720069 |
| 125 | Abnormal glycosylation (HP:0012345) | 1.69720069 |
| 126 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.69720069 |
| 127 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.69720069 |
| 128 | Myelodysplasia (HP:0002863) | 1.68772723 |
| 129 | Protrusio acetabuli (HP:0003179) | 1.68407407 |
| 130 | Nonimmune hydrops fetalis (HP:0001790) | 1.67780988 |
| 131 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.67448602 |
| 132 | Autoimmune thrombocytopenia (HP:0001973) | 1.66499762 |
| 133 | Poikiloderma (HP:0001029) | 1.65938946 |
| 134 | Hyperammonemia (HP:0001987) | 1.65902535 |
| 135 | Short nail (HP:0001799) | 1.65749372 |
| 136 | Lethargy (HP:0001254) | 1.65720275 |
| 137 | Agnosia (HP:0010524) | 1.65713316 |
| 138 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.62993043 |
| 139 | Poor head control (HP:0002421) | 1.62530862 |
| 140 | Hypoplasia of the pons (HP:0012110) | 1.61816474 |
| 141 | Reduced antithrombin III activity (HP:0001976) | 1.61585478 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.60286770 |
| 143 | Peritonitis (HP:0002586) | 1.60222957 |
| 144 | Ureteral stenosis (HP:0000071) | 1.59697642 |
| 145 | Myositis (HP:0100614) | 1.58740814 |
| 146 | IgA deficiency (HP:0002720) | 1.58162452 |
| 147 | High pitched voice (HP:0001620) | 1.57774356 |
| 148 | Verrucae (HP:0200043) | 1.57686295 |
| 149 | Papilloma (HP:0012740) | 1.57686295 |
| 150 | Chromsome breakage (HP:0040012) | 1.57289539 |
| 151 | Premature graying of hair (HP:0002216) | 1.56481424 |
| 152 | Adenoma sebaceum (HP:0009720) | 1.56158226 |
| 153 | Angiofibromas (HP:0010615) | 1.56158226 |
| 154 | Abnormal hemoglobin (HP:0011902) | 1.54632371 |
| 155 | Biliary tract neoplasm (HP:0100574) | 1.53536461 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.53168998 |
| 157 | Rectal prolapse (HP:0002035) | 1.52997802 |
| 158 | Periodontitis (HP:0000704) | 1.52971516 |
| 159 | Progressive muscle weakness (HP:0003323) | 1.52665964 |
| 160 | Vertebral compression fractures (HP:0002953) | 1.52627693 |
| 161 | Skin ulcer (HP:0200042) | 1.52376086 |
| 162 | Gastrointestinal dysmotility (HP:0002579) | 1.52193471 |
| 163 | Lymphoma (HP:0002665) | 1.52080237 |
| 164 | Spinal cord compression (HP:0002176) | 1.51950824 |
| 165 | Recurrent bronchitis (HP:0002837) | 1.50920614 |
| 166 | Ureteral obstruction (HP:0006000) | 1.50848760 |
| 167 | Severe short stature (HP:0003510) | 1.50581125 |
| 168 | Abnormal platelet volume (HP:0011876) | 1.50500701 |
| 169 | Gastrointestinal inflammation (HP:0004386) | 1.50059975 |
| 170 | Ulnar deviation of the wrist (HP:0003049) | 1.49844626 |
| 171 | Radial bowing (HP:0002986) | 1.49424181 |
| 172 | Abnormality of T cell number (HP:0011839) | 1.48723917 |
| 173 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.48511840 |
| 174 | Hand muscle atrophy (HP:0009130) | 1.48091645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.57622245 |
| 2 | VRK2 | 3.11275999 |
| 3 | EEF2K | 2.96258985 |
| 4 | PKN2 | 2.45765757 |
| 5 | MAP3K10 | 2.44414190 |
| 6 | TRIB3 | 2.33713761 |
| 7 | TESK2 | 2.31407514 |
| 8 | PBK | 2.30066256 |
| 9 | TESK1 | 2.25937775 |
| 10 | BUB1 | 2.22324431 |
| 11 | CDC7 | 2.18288032 |
| 12 | RPS6KB2 | 2.17374220 |
| 13 | ERN1 | 2.15521642 |
| 14 | PDK2 | 2.14305583 |
| 15 | TLK1 | 2.14271405 |
| 16 | SMG1 | 2.01365519 |
| 17 | SCYL2 | 1.94520537 |
| 18 | EIF2AK1 | 1.84300677 |
| 19 | PIM2 | 1.79944718 |
| 20 | PASK | 1.79825766 |
| 21 | TAOK2 | 1.75470428 |
| 22 | LRRK2 | 1.73538051 |
| 23 | MAP4K1 | 1.73467734 |
| 24 | RPS6KA4 | 1.73383027 |
| 25 | NEK2 | 1.73349461 |
| 26 | WEE1 | 1.71374735 |
| 27 | ABL2 | 1.66739403 |
| 28 | STK10 | 1.63236861 |
| 29 | MAPKAPK3 | 1.62689061 |
| 30 | ARAF | 1.56336637 |
| 31 | EIF2AK3 | 1.55138365 |
| 32 | MAP3K8 | 1.38794938 |
| 33 | BLK | 1.38012523 |
| 34 | EPHA2 | 1.34031369 |
| 35 | FLT3 | 1.31073330 |
| 36 | MST4 | 1.27772220 |
| 37 | PAK4 | 1.26651726 |
| 38 | AURKB | 1.23983649 |
| 39 | KDR | 1.18193796 |
| 40 | SRPK1 | 1.18155956 |
| 41 | PTK6 | 1.18151062 |
| 42 | MAP3K11 | 1.15818445 |
| 43 | JAK3 | 1.14782460 |
| 44 | TTK | 1.14331999 |
| 45 | CDK12 | 1.13630324 |
| 46 | LIMK1 | 1.13428868 |
| 47 | TYK2 | 1.12322437 |
| 48 | BMPR2 | 1.12247069 |
| 49 | CDK7 | 1.10850411 |
| 50 | GRK7 | 1.10028147 |
| 51 | ZAP70 | 1.10002853 |
| 52 | MAP3K3 | 1.07755440 |
| 53 | MAP2K3 | 1.07483150 |
| 54 | IRAK4 | 1.03496383 |
| 55 | PIM1 | 1.02982527 |
| 56 | MAP2K2 | 0.99220924 |
| 57 | CDK4 | 0.98205723 |
| 58 | PLK1 | 0.95789460 |
| 59 | CCNB1 | 0.95002002 |
| 60 | TBK1 | 0.94806586 |
| 61 | TGFBR1 | 0.94443562 |
| 62 | IKBKE | 0.93810369 |
| 63 | BRSK2 | 0.91112714 |
| 64 | NEK1 | 0.89755632 |
| 65 | ATR | 0.87820572 |
| 66 | MATK | 0.87186256 |
| 67 | GRK6 | 0.86775135 |
| 68 | BTK | 0.86496311 |
| 69 | VRK1 | 0.85190393 |
| 70 | DYRK3 | 0.82636794 |
| 71 | STK4 | 0.81109335 |
| 72 | ICK | 0.80093985 |
| 73 | TTN | 0.79192156 |
| 74 | BRAF | 0.78333122 |
| 75 | ILK | 0.75945815 |
| 76 | AURKA | 0.74860053 |
| 77 | RIPK4 | 0.74138957 |
| 78 | CLK1 | 0.72638214 |
| 79 | MAP3K12 | 0.72162815 |
| 80 | BCKDK | 0.71042903 |
| 81 | PLK4 | 0.70347566 |
| 82 | ACVR1B | 0.70092373 |
| 83 | DAPK1 | 0.69719247 |
| 84 | PAK1 | 0.69610392 |
| 85 | MAPKAPK5 | 0.66894512 |
| 86 | IKBKB | 0.65299279 |
| 87 | PAK2 | 0.64286248 |
| 88 | MAPK11 | 0.64247310 |
| 89 | TSSK6 | 0.64101225 |
| 90 | TEC | 0.63811454 |
| 91 | CHEK2 | 0.61288699 |
| 92 | PRKCI | 0.60805881 |
| 93 | CDK6 | 0.59830696 |
| 94 | TRPM7 | 0.59078291 |
| 95 | CAMKK2 | 0.59045320 |
| 96 | CDK8 | 0.58840281 |
| 97 | CHEK1 | 0.56343418 |
| 98 | MAPKAPK2 | 0.55906231 |
| 99 | MAP3K14 | 0.55415600 |
| 100 | MOS | 0.55330891 |
| 101 | STK16 | 0.55189317 |
| 102 | CHUK | 0.55135524 |
| 103 | IRAK3 | 0.54907582 |
| 104 | DAPK3 | 0.54330837 |
| 105 | ADRBK2 | 0.54250350 |
| 106 | TGFBR2 | 0.52937698 |
| 107 | BMX | 0.52749665 |
| 108 | KIT | 0.52200739 |
| 109 | FRK | 0.51814265 |
| 110 | ZAK | 0.51715945 |
| 111 | NEK9 | 0.51523010 |
| 112 | RIPK1 | 0.51515140 |
| 113 | NUAK1 | 0.49538054 |
| 114 | PRKG2 | 0.48677905 |
| 115 | NME1 | 0.46886945 |
| 116 | CSF1R | 0.46233715 |
| 117 | ITK | 0.45626898 |
| 118 | MST1R | 0.42706652 |
| 119 | ALK | 0.42626671 |
| 120 | CSK | 0.42576458 |
| 121 | MYLK | 0.41851642 |
| 122 | IRAK1 | 0.40932446 |
| 123 | CSNK2A2 | 0.40868893 |
| 124 | TAOK3 | 0.40802313 |
| 125 | EIF2AK2 | 0.40311099 |
| 126 | LMTK2 | 0.39732014 |
| 127 | LCK | 0.39646225 |
| 128 | ATM | 0.39455669 |
| 129 | RPS6KC1 | 0.39396920 |
| 130 | RPS6KL1 | 0.39396920 |
| 131 | BRSK1 | 0.38974752 |
| 132 | STK3 | 0.38954726 |
| 133 | PRPF4B | 0.37873789 |
| 134 | RPS6KA5 | 0.37603607 |
| 135 | CDC42BPA | 0.37174790 |
| 136 | MUSK | 0.37016110 |
| 137 | CSNK2A1 | 0.36384730 |
| 138 | DDR2 | 0.36277583 |
| 139 | RAF1 | 0.35538156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.11203937 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.10578039 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.21364654 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.53607285 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.40057724 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.30224241 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.29640208 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.11854082 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.06976767 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.04973470 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.02046444 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.96562437 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.90198037 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.83900261 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81226665 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.76505532 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.75152924 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73634405 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.70634457 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.70568846 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61609832 |
| 22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.58196078 |
| 23 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.52460510 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43973259 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.41592816 |
| 26 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.35380909 |
| 27 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.32381508 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27821602 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26354021 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.25982408 |
| 31 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.24181350 |
| 32 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22581878 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.22484037 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.19731859 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18592518 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.18384694 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14206588 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12422866 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12141742 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12028427 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06020963 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.04982961 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04258111 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03210956 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02546119 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.02472342 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98982715 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.98877365 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96931255 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96926452 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95509387 |
| 52 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91464162 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.91344237 |
| 54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.87642573 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.87094427 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86032195 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84778144 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84472989 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84144043 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83438585 |
| 61 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83382449 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83274735 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83110788 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82396930 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.82055818 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81828274 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81587990 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81429695 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80566462 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79272036 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.79255738 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77188633 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76780536 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75014176 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73910424 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.73838569 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71133318 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70585710 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70216345 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.69813198 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69258397 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68809911 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68227028 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63611033 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62708026 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62500885 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.61471715 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60324286 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59639964 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59633207 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.58582180 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58434947 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.56810037 |
| 94 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56573069 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.56568963 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56249104 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56194582 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55362448 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.54314198 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.54079707 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52491982 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52322898 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51205752 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51061202 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50607514 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50561616 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50414777 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50075690 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49043169 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48739491 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48489936 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47131876 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46467380 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46393342 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46142919 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46047355 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46022657 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45680480 |
| 119 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44868014 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44649418 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44227282 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.43726066 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43635707 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43510596 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42957167 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41262161 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41205092 |
| 128 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41151316 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41107849 |
| 130 | Tuberculosis_Homo sapiens_hsa05152 | 0.40469284 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38588507 |
| 132 | Adherens junction_Homo sapiens_hsa04520 | 0.36509398 |
| 133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34205392 |
| 134 | Prostate cancer_Homo sapiens_hsa05215 | 0.33699636 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33532295 |
| 136 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33460002 |

